跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 15,355 条关于
“Factor V”
全部
15,355
临床试验
10,371
药物
1,355
机构
65
资讯
3,564
10个月前
GeneVentiv Therapeutics Receives FDA Alignment on Gene Therapy Development Plan for Hemophilia A
去年
Samsung Bioepis' Opuviz (Aflibercept) Biosimilar Receives European Approval for Ophthalmic Use
去年
Sun Pharma Receives CDSCO Panel Nod for Aflibercept Phase III Study in Wet AMD
去年
FDA-Approved Cimerli: First Interchangeable Biosimilar for Ocular Conditions Now Available
2年前
Boehringer Ingelheim's Nintedanib Demonstrates Positive Phase III Results in Idiopathic Pulmonary Fibrosis
去年
Formycon's Aflibercept Biosimilar FYB203 Receives Positive CHMP Opinion for EU Approval
去年
Roche Canada Secures Public Funding for Vabysmo in Quebec for Retinal Vein Occlusion Treatment
去年
Zhaoke Ophthalmology's TAB014 Meets Primary Endpoint in Phase III wAMD Trial
去年
Formycon's Aflibercept Biosimilar (FYB203) Receives Positive CHMP Opinion for EU Approval
去年
Study Confirms CT-P42 Therapeutic Equivalence to Reference Aflibercept in DME
第 1 页,共 357 页
上一页
下一页